Author: Rob

In this issue of our newsletter we provide further validation that optimizing AMPK ( 5- adenosine monophosphate-activated protein kinase) levels in patients is a valuable clinical practice which can have a significant impact on a wide spectrum of health issues including CVD, blood sugar balance and diabetes, neurodegenerative conditions (such as Alzheimer’s), cancers  and more. It can facilitate health enhancing activities such as improved autophagy,  mitochondrial biogenesis, downregulation of NF-kappaB and many more.

Continue reading